Newstral
Article
Fft.com on 2015-11-15 17:37
Allergan warns US on blocking tax deals
Related news
- Pfizer drops merger with Botox maker Allergan after US tax clampdownexpressandstar.com
- Pfizer-Allergan deal refocuses market on US tax-inversion rulesbangordailynews.com
- FPfizer seeks US support for Allergan dealft.com
- FPfizer says US cannot halt Allergan dealft.com
- Offshore tax benefits: Pfizer-Allergan deal is business swallowing the silly pillsSydney Morning Herald
- White House Tax Moves Sink Pfizer-Allergan Mergerbhcourier.com
- Pfizer-Allergan deal draws criticism as U.S. tax dodgeseattletimes.com
- Pfizer, Allergan merger talks raise tax hacklesReuters
- FAllergan shares drop on tax inversion curbsft.com
- Pfizer seen avoiding $48 billion in tax through Allergan mergerSydney Morning Herald
- New tax-inversion rules kill proposed Allergan-Pfizer merger (+video)heralddemocrat.com
- FDeals challenge US inversions clampdownft.com
- AUS stocks slip on Allergan, Pfizer dealafr.com
- Britain warns EU that blocking vaccin...expressandstar.com
- FPolitical risk clouds Pfizer-Allergan dealft.com
- New tax-inversion rules raise doubts about Allergan-Pfizer dealLA Times
- US warns of punitive actions for Lebanese blocking reformsSeattle Times
- FAllergan sells generic drugs unit to Tevaft.com
- $160B deal to combine Pfizer, Allergan raises outcryThe Salt Lake Tribune